Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Citius Pharmaceuticals Inc (NQ: CTXR )

2.740 USD +0.140 (+5.39%)
Streaming Delayed Price Updated: 10:31 AM EDT, Jun 14, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,145,529
Open 2.620
Bid (Size) 2.740 (15)
Ask (Size) 2.750 (122)
Prev. Close 2.600
Today's Range 2.620 - 2.790
52wk Range 0.7800 - 2.900
Shares Outstanding 135,473,947
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Citius Pharmaceuticals Achieves Next Interim Analysis Milestone in its Mino-Lok® Phase 3 Trial
- Independent Data Monitoring Committee (DMC) to review Mino-Lok® safety, superiority, and futility data at upcoming meeting scheduled for June 29, 2021- 
From PR Newswire
Citius Pharmaceuticals to be Added to Russell 2000® Index
Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products with a... 
From PR Newswire

Performance

YTD
+163.47%
+163.47%
1 Month
+39.80%
+39.80%
3 Month
+32.37%
+32.37%
6 Month
+156.08%
+156.08%
1 Year
+209.69%
+209.69%

More News

Read More
Citius Pharmaceuticals Selected to Receive Best Poster Award at the International Society for Cell and Gene Therapy 2021 Annual Meeting
From PR Newswire
Citius Pharmaceuticals to Feature Updated Positive Interim Results of i-MSC Study During Poster Presentation at International Society for Cell and Gene Therapy
From PR Newswire
Citius Pharmaceuticals, Inc. Announces Appointment of Ilanit Allen as Vice President, Corporate Communications and Investor Relations
From PR Newswire
Penny Stocks to Buy? 3 That WallStreetBets Won’t Stop Talking About
Tags Market News
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
Citius Pharmaceuticals, Inc. Reports Second Fiscal Quarter 2021 Financial Results and Provides General Business Update
From PR Newswire
Citius Pharmaceuticals to Participate in Fireside Chat at the Gabelli Funds Virtual Microcap Symposium on Tuesday, May 18
From PR Newswire
G.research Hosts Its Inaugural Micro-Cap Conference
From Business Wire News Releases
G.research to Host Its Inaugural Micro-Cap Symposium on May 18, 2021
From Business Wire News Releases
Citius Pharmaceuticals to Present Mino-Lok® and COVID-related Respiratory Treatment Update at Benzinga Global Small Cap Conference on Thursday, May 13
From PR Newswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.